Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Verisante Technology Inc. V.VRS


Primary Symbol: V.VER.H

Verisante Technology Inc is a Canada based medical device company. It is engaged in commercializing medical systems for the early detection of cancer. The products of the company are Verisante Aura which is for skin cancer detection and Verisante Core which is for lung, colon and cervical cancer detection. It utilizes a cancer detection platform while the operating software and probe technology. The group generates revenue from the sale and renting of its medical devices.


TSXV:VER.H - Post by User

Bullboard Posts
Post by metalbrainon Jul 27, 2012 3:42pm
305 Views
Post# 20160512

Hold On!

Hold On!

BMO had put up 91000 shares at a ask of 56 cents yesterday, thus causing holders to question why such a big sell order and thus prompting them to sell below BMO's ask.  Once those 91000 shares came close to being taken out today, BMO pulled the order and reduced their order amount to 41000.  Today BMO has been cross trading and working with anonymous, next market day it will be somebody else playing games.  Folks it's all choreographed so that the common investor questions why anyone would sell a big lot like that in such a promising company and for some their frustration  questions their dd to the point where they end up selling below such an order to the delight of the MM's.  Big medical company acquisitions are up 40% from last year and one can bet their eyes are on VRS unique cancer detection technology, so hold on and don't get played by the big players, for VRS will have it's day soon enough. 

Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse